Asset Details
Do you wish to reserve the book?
Evaluation of Similar Genetic Pathophysiology Underlying Diabetes Mellitus and Peyronie’s Disease: WNT-2 and TGF Beta-1 Genes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluation of Similar Genetic Pathophysiology Underlying Diabetes Mellitus and Peyronie’s Disease: WNT-2 and TGF Beta-1 Genes
Do you wish to request the book?
Evaluation of Similar Genetic Pathophysiology Underlying Diabetes Mellitus and Peyronie’s Disease: WNT-2 and TGF Beta-1 Genes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluation of Similar Genetic Pathophysiology Underlying Diabetes Mellitus and Peyronie’s Disease: WNT-2 and TGF Beta-1 Genes
2024
Overview
Aim:Some recent studies on PD have focused on the WNT-2 and TGF-β1 gene loci, but its genetic basis is still not clearly known. In this context, we aimed to evaluate the presence of WNT-2 and TGF-β1 gene expression and genetic similarity between patients with Peyronie’s disease (PD) and comorbidities, especially diabetes mellitus (DM).Methods:Between May 2020 and April 2021, 57 patients diagnosed with PD were included in this cross-sectional study. The presence of comorbidities [Dupuytren’s contracture (DC), DM, hypertension (HT), dyslipidemia, and erectile dysfunction (ED)] was recorded. For genetic analysis, the WNT-2 and TGF-β1 genes were analyzed in the patients’ serum.Results:The mean age was found to be 50.2. 45.6% of the patients had DM, 19.1% had HT, 14% had dyslipidemia, 5.3% had DC, and 40.4% had ED. TGF-β1 gene expression was found to be increased in all patients; WNT-2 gene expression was found to be increased in 80.7%. When subtypes of the TGF-β1 and WNT-2 gene expression were analyzed, 52.6% of patients with WNT-2 gene expression and 95.5% of patients with TGF-β1 gene expression were found to be homozygous, and the others were found to be heterozygous. Patients with DM and PD had significantly higher homozygous WNT-2 gene expression (p=0.03). No significant relationship was found between other comorbidities and these genes.Conclusion:Homozygous WNT-2 gene expression was found to be increased in PD with DM. These data could be used to explain the genetic pathophysiology of PD in diabetic patients.
